|
US2021069248A1
|
|
Ca2 compositions and methods for tunable regulation
|
|
WO2021046451A1
|
|
Compositions and methods for dhfr tunable protein regulation
|
|
WO2020252405A1
|
|
Ca2 compositions and methods for tunable regulation
|
|
WO2020252404A1
|
|
Ca2 compositions and methods for tunable regulation
|
|
WO2020185628A1
|
|
Cd40l compositions and methods for tunable regulation
|
|
WO2020185632A1
|
|
Human carbonic anhydrase 2 compositions and methods for tunable regulation
|
|
WO2020123716A1
|
|
Membrane bound il12 compositions and methods for tunable regulation
|
|
WO2020086742A1
|
|
Er tunable protein regulation
|
|
US2020172879A1
|
|
Dhfr tunable protein regulation
|
|
WO2021040736A1
|
|
Tandem cd19 car-based compositions and methods for immunotherapy
|
|
WO2019241315A1
|
|
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
EP3638289A1
|
|
Pde5 compositions and methods for immunotherapy
|
|
CN110831961A
|
|
CD19 compositions and methods for immunotherapy
|
|
WO2018161026A1
|
|
Il15 compositions and methods for immunotherapy
|
|
WO2018161038A1
|
|
Il12 compositions and methods for immunotherapy
|
|
WO2018161000A1
|
|
Dhfr tunable protein regulation
|
|
AU2018226857A1
|
|
Compositions and methods for immunotherapy
|
|
EP3443001A2
|
|
Regulated biocircuit systems
|
